share_log

Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket

Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket

为什么 Celyad Oncology 的交易价格上涨了 31% 以上;这里有 29 只股票在盘前走势
Benzinga Real-time News ·  2022/08/01 18:45
Gainers
赢家
MAIA Biotechnology, Inc. (NASDAQ:MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00 per share. Aethlon Medical, Inc. (NASDAQ:AEMD) rose 33% to $1.33 in pre-market trading after dropping over 7% on Friday. GeoVax Labs, Inc. (NASDAQ:GOVX) rose 32.2% to $3.61 in pre-market trading amid continued strength in monkeypox names. The company also recently announced the publication of a peer-reviewed animal efficacy study of its modified vaccine Ankara vectored vaccine against Sudan ebolavirus. Celyad Oncology SA (NASDAQ:CYAD) rose 31.5% to $2.29 in pre-market trading after...
Maia生物技术公司纳斯达克(Sequoia Capital:MAIA)周五大涨30%后,盘前交易中上涨37.9%,至8.00美元。该公司同意最初以每股5澳元的价格向公众发行200万股。 埃斯隆医...

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发